CITIUS ONCOLOGY, INC. 8-K

What Happened

• On May 15, 2026, Citius Oncology, Inc. announced its results of operations for the second quarter of fiscal 2026 by issuing a press release. The press release is furnished as Exhibit 99.1 to the Form 8-K and is incorporated by reference. The 8-K’s Item reported the company’s quarterly results; the filing itself does not reproduce the full financial figures.

Key Details

• Filing date: May 15, 2026 (Form 8-K).
• Event: Results of operations for Q2 of fiscal 2026 announced (Item 2.02).
• Exhibit: Press release dated May 15, 2026 furnished as Exhibit 99.1.
• Other: Cover page iXBRL interactive data file included with the filing (Exhibit 104).

Why It Matters

• Quarterly results and any accompanying commentary or revenue/earnings figures in the press release are material for investors assessing the company’s recent operational and financial performance. Investors should read Exhibit 99.1 (the press release) for the specific revenue, earnings or operational metrics and monitor subsequent filings (e.g., 10-Q) for full financial statements and context. There are no officer resignations, mergers, or other corporate actions reported in this 8-K.